Jin Mo Goo

Dr. Jin Mo Goo

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2004 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
SPSeong Ho Park
Seong Ho Park
JGJin Mo Goo
Jin Mo Goo
CJChan-Hee Jo
Chan-Hee Jo
Park SH, et al. Korean J Radiol. 2004 Jan-Mar;5(1):11-18. http://dx.doi.org/10.3348/kjr.2004.5.1.11

1 January 2019 in Radiology
Verified
Journal Article
Closed access
Ju Gang NamJu Gang Nam
Ju Gang Nam
SPSunggyun Park
Sunggyun Park
EHEui Jin Hwang
Eui Jin Hwang
JLJong Hyuk Lee
Jong Hyuk Lee
KJKwang-Nam Jin
Kwang-Nam Jin
CPChang Park
Chang Park
Our deep learning–based automatic detection algorithm outperformed physicians in radiograph classification and nodule detection performance for malignant pulmonary nodules on chest radiographs, and when used as a second reader, it enhanced physicians’ performances. Purpose To develop and validate a deep learning–based automatic detection algorithm (DLAD) for malignant pulmonary nodules on chest radiographs and to compare its performance with physicians including thoracic radiologists. Materials and Methods For this retrospective study, DLAD was developed by using 43 292 chest radiographs (normal radiograph–to–nodule radiograph ratio, 34 067:9225) in 34 676 patients (healthy-to-nodule ratio, 30 784:3892; 19 230 men [mean age, 52.8 years; age range, 18–99 years]; 15 446 women [mean age, 52.3 years; age range, 18–98 years]) obtained between 2010 and 2015, which were labeled and partially annotated by 13 board-certified radiologists, in a convolutional neural network. Radiograph classification and nodule detection performances of DLAD were validated by using one internal and four external data sets from three South Korean hospitals and one U.S. hospital. For internal and external validation, radiograph classification and nodule detection performances of DLAD were evalua...

1 February 2024 in Radiology
Verified
Journal Article
Closed access
ABAlexander A. Bankier
Alexander A. Bankier
HMHeber MacMahon
Heber MacMahon
TCThomas Colby
Thomas Colby
PGPierre Alain Gevenois
Pierre Alain Gevenois
JGJin Mo Goo
Jin Mo Goo
DNDavid P. Naidich
David P. Naidich
Members of the Fleischner Society have compiled a glossary of terms for thoracic imaging that replaces previous glossaries published in 1984, 1996, and 2008, respectively. The impetus to update the previous version arose from multiple considerations. These include an awareness that new terms and concepts have emerged, others have become obsolete, and the usage of some terms has either changed or become inconsistent to a degree that warranted a new definition. This latest glossary is focused on terms of clinical importance and on those whose meaning may be perceived as vague or ambiguous. As with previous versions, the aim of the present glossary is to establish standardization of terminology for thoracic radiology and, thereby, to facilitate communications between radiologists and clinicians. Moreover, the present glossary aims to contribute to a more stringent use of terminology, increasingly required for structured reporting and accurate searches in large databases. Compared with the previous version, the number of images (chest radiography and CT) in the current version has substantially increased. The authors hope that this will enhance its educational and practical value. All definitions and images are hyperlinked throughout the text. Click on each figure callout to view corresponding image. © RSNA, 2024 Supplemental material is available for this article. See also the editorials by Bhalla and Powell in this issue.

1 March 2021 in Radiology
Verified
Journal Article
Open access
PDF file
TJTakeshi Johkoh
Takeshi Johkoh
KLKyung Soo Lee
Kyung Soo Lee
MNMizuki Nishino
Mizuki Nishino
WTWilliam D. Travis
William D. Travis
JRJay Ryu
Jay Ryu
HHHiroto Hatabu
Hiroto Hatabu
Increasing use of molecular targeting agents and immune checkpoint inhibitors has increased the frequency and broadened the spectrum of lung toxicity, particularly in patients with cancer. In this position paper from the Fleischner Society, the authors provide diagnostic criteria and management recommendations of drug-related pneumonitis for radiologists, clinicians, clinical trialists, and trial sponsors.

1 December 2019 in Radiology
Verified
Journal Article
Open access
EHEui Jin Hwang
Eui Jin Hwang
Ju Gang NamJu Gang Nam
Ju Gang Nam
WLWoo Hyeon Lim
Woo Hyeon Lim
SPSae Jin Park
Sae Jin Park
YJYun Soo Jeong
Yun Soo Jeong
CPChang Park
Chang Park
Use of a commercially available deep learning algorithm for evaluating chest radiographs resulted in identification of clinically relevant abnormalities on emergency department radiographs and impr... BackgroundThe performance of a deep learning (DL) algorithm should be validated in actual clinical situations, before its clinical implementation.PurposeTo evaluate the performance of a DL algorith...

1 April 2023 in Radiology
Verified
Journal Article
Closed access
Ju Gang NamJu Gang Nam
Ju Gang Nam
EHEui Jin Hwang
Eui Jin Hwang
JKJayoun Kim
Jayoun Kim
NPNanhee Park
Nanhee Park
ELEun Hee Lee
Eun Hee Lee
JGJin Mo Goo
Jin Mo Goo
Background The impact of artificial intelligence (AI)-based computer-aided detection (CAD) software has not been prospectively explored in real-world populations. Purpose To investigate whether commercial AI-based CAD software could improve the detection rate of actionable lung nodules on chest radiographs in participants undergoing health checkups. Materials and Methods In this single-center, pragmatic, open-label randomized controlled trial, participants who underwent chest radiography between July 2020 and December 2021 in a health screening center were enrolled and randomized into intervention (AI group) and control (non-AI group) arms. One of three designated radiologists with 13-36 years of experience interpreted each radiograph, referring to the AI-based CAD results for the AI group. The primary outcome was the detection rate, that is, the number of true-positive radiographs divided by the total number of radiographs, of actionable lung nodules confirmed on CT scans obtained within 3 months. Actionable nodules were defined as solid nodules larger than 8 mm or subsolid nodules with a solid portion larger than 6 mm (Lung Imaging Reporting and Data System, or Lung-RADS, category 4). Secondary outcomes included the positive-report rate, sensitivity, false-referral rate, and malignant lung nodule detection rate. Clinical outcomes were compared between the two groups using univariable logistic regression analyses. Results A total of 10 476 participants (median age, 59 years [IQR, 50-66 years]; 5121 men) were randomized to an AI group (n = 5238) or non-AI group (n = 5238). The trial met the predefined primary outcome, demonstrating an improved detection rate of actionable nodules in the AI group compared with the non-AI group (0.59% [31 of 5238 participants] vs 0.25% [13 of 5238 participants], respectively; odds ratio, 2.4; 95% CI: 1.3, 4.7; P = .008). The detection rate for malignant lung nodules was higher in the AI group compared with the non-AI group (0.15% [eight of 5238 participants] vs 0.0% [0 of 5238 participants], respectively; P = .008). The AI and non-AI groups showed similar false-referral rates (45.9% [56 of 122 participants] vs 56.0% [56 of 100 participants], respectively; P = .14) and positive-report rates (2.3% [122 of 5238 participants] vs 1.9% [100 of 5238 participants]; P = .14). Conclusion In health checkup participants, artificial intelligence-based software improved the detection of actionable lung nodules on chest radiographs. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Auffermann in this isssue.